Skip to main content
SpringerLink
Log in

Academic Detailing in the New Era of Diabetes Medication Management

  • Health Care Delivery Systems and Implementation in Diabetes (ME McDonnell and AR Sadhu, Section Editors)
  • Published:
Current Diabetes Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

Educating clinicians on how to improve the medical management of type 2 diabetes in the modern pharmacologic era represents an enormous challenge given the number of medications available and the diversity across guideline recommendations. Academic detailing uses active social marketing techniques to deliver in-office, face-to-face educational encounters between a trained clinical educator (academic detailer) and a primary care clinician and can improve the quality of prescribing and management decisions, leading to better patient outcomes.

Recent Findings

This updated review provides context on how academic detailing programs can improve diabetes-related clinical knowledge and practice among primary care providers, incorporating the perspective of a field-based academic detailer. It also profiles 4 diabetes-specific academic detailing programs varying in geographic scope and detailing approach, based in Massachusetts, Pennsylvania, Vermont, and Saskatchewan Province (Canada).

Summary

Academic detailing can effectively overcome challenges to increasing the evidence-based use of newer glucose-lowering medications in primary care settings.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Soumerai SB, Avorn JL. Principles of educational outreach (‘academic detailing’) to improve clinical decision making. JAMA. 1990;263:549–56.

    Article  CAS  Google Scholar 

  2. • Avorn J. Academic detailing:“marketing” the best evidence to clinicians. JAMA. 2017;317(4):361–2. This review describes the theoretical framework and evidence-base supporting academic detailing as one approach to improve the care of patients.

    Article  Google Scholar 

  3. Majumdar SR, Guirguis LM, Toth EL, Lewanczuk RZ, Lee T, Johnson JA. Controlled trial of a multifaceted intervention for improving quality of care for rural patients with type 2 diabetes. Diabetes Care. 2003;26(11):3061–6.

    Article  Google Scholar 

  4. Trombetta DP, Heller DA. Can academic detailing move the needle for patients with diabetes in a state-based prescription drug benefit program? American Health & Drug Benefits. 2019;12(2):94.

    Google Scholar 

  5. Awad MH, Ulbrich TR, Furdich KM, Schneider SR, Gothard DM. The effect of pharmacy-led, small-group academic detailing on prescribing patterns in an ambulatory care clinic. J Pharm Technol. 2019;35(2):56–63.

    Article  Google Scholar 

  6. •• Fischer MA. Academic detailing in diabetes: using outreach education to improve the quality of care. Curr Diab Rep. 2016;16(10):98. This review describes academic detailing as an educational approach to improve diabetes care.

    Article  Google Scholar 

  7. Cefalu WT, Kaul S, Gerstein HC, et al. Cardiovascular outcomes trials in type 2 diabetes: where do we go from here? Reflections from a diabetes care editors’ expert forum. Diabetes Care. 2018;41(1):14–31.

    Article  CAS  Google Scholar 

  8. Davies MJ, D’Alessio DA, Fradkin J, et al. Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2018;61(12):2461–98.

    Article  Google Scholar 

  9. Inzucchi S. Clinical diabetes. Philadelphia: Saunders; 2006.

    Google Scholar 

  10. Alosa Health, Inc. Health A. Alosa health clinical modules. 2019; https://alosahealth.org/clinical-modules/. Accessed 8/15/2019.

  11. Gerstein HC, Colhoun HM, Dagenais GR, et al. Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial. American Diabetes Association. 2019;394(10193):131–8.

    CAS  Google Scholar 

  12. Care ADAJD. 9. Pharmacologic approaches to glycemic treatment: Standards of Medical Care in Diabetes—2019. Diabetes Care. 2019;42(Supplement 1):S90–S102.

    Article  Google Scholar 

  13. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71(19):e127–248.

    Google Scholar 

  14. Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the american college of cardiology/american heart association task force on clinical practice guidelines. Journal of the American College of Cardiology. 2019;139(25):e1082–143.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA, USA

    Jing Luo & Michael A. Fischer

  2. Alosa Health, Boston, MA, USA

    Jing Luo, Ellen Dancel, Sandeep Bains & Paul Fanikos

Authors
  1. Jing Luo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ellen Dancel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sandeep Bains
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Paul Fanikos
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Michael A. Fischer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jing Luo.

Ethics declarations

Conflict of Interest

Jing Luo, Michael A. Fischer and Sandeep Bains consult for Alosa Health. Jing Luo also receives personal fees from Health Action International.

Ellen Dancel and Paul Fanikos are employees of Alosa Health.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Health Care Delivery Systems and Implementation in Diabetes

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Luo, J., Dancel, E., Bains, S. et al. Academic Detailing in the New Era of Diabetes Medication Management. Curr Diab Rep 19, 140 (2019). https://doi.org/10.1007/s11892-019-1252-0

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11892-019-1252-0

Keywords

Search

Navigation